186 related articles for article (PubMed ID: 16170384)
41. Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo.
Iwado E; Daido S; Kondo Y; Kondo S
Int J Oncol; 2007 Nov; 31(5):1087-95. PubMed ID: 17912434
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of telomerase activity by preventing proper assemblage.
Keppler BR; Jarstfer MB
Biochemistry; 2004 Jan; 43(2):334-43. PubMed ID: 14717587
[TBL] [Abstract][Full Text] [Related]
43. Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy.
Ji XM; Xie CH; Fang MH; Zhou FX; Zhang WJ; Zhang MS; Zhou YF
Acta Pharmacol Sin; 2006 Sep; 27(9):1185-91. PubMed ID: 16923339
[TBL] [Abstract][Full Text] [Related]
44. Growth defects in mouse telomerase RNA-deficient cells expressing a template-mutated mouse telomerase RNA.
Marie-Egyptienne DT; Brault ME; Nimmo GA; Londoño-Vallejo JA; Autexier C
Cancer Lett; 2009 Mar; 275(2):266-76. PubMed ID: 19056167
[TBL] [Abstract][Full Text] [Related]
45. Marked transfection enhancement by the DPL (DNA/peptide/lipid) complex.
Moon IJ; Kang H; Seu YB; Chang BC; Song DK; Park JG
Int J Mol Med; 2007 Oct; 20(4):429-37. PubMed ID: 17786272
[TBL] [Abstract][Full Text] [Related]
46. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues.
Avilion AA; Piatyszek MA; Gupta J; Shay JW; Bacchetti S; Greider CW
Cancer Res; 1996 Feb; 56(3):645-50. PubMed ID: 8564985
[TBL] [Abstract][Full Text] [Related]
47. Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo.
You Y; Pu P; Huang Q; Xia Z; Wang C; Wang G; Yu C; Yu JJ; Reed E; Li QQ
Int J Oncol; 2006 May; 28(5):1225-32. PubMed ID: 16596239
[TBL] [Abstract][Full Text] [Related]
48. Telomerase inhibition by synthetic nucleic acids and chemosensitization in human bladder cancer cell lines.
Kraemer K; Fuessel S; Meye A
Methods Mol Biol; 2007; 405():9-22. PubMed ID: 18369813
[TBL] [Abstract][Full Text] [Related]
49. A novel telomerase template antagonist (GRN163) as a potential anticancer agent.
Asai A; Oshima Y; Yamamoto Y; Uochi TA; Kusaka H; Akinaga S; Yamashita Y; Pongracz K; Pruzan R; Wunder E; Piatyszek M; Li S; Chin AC; Harley CB; Gryaznov S
Cancer Res; 2003 Jul; 63(14):3931-9. PubMed ID: 12873987
[TBL] [Abstract][Full Text] [Related]
50. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity.
Zou L; Zhang P; Luo C; Tu Z
Urology; 2006 Jun; 67(6):1335-40. PubMed ID: 16765199
[TBL] [Abstract][Full Text] [Related]
51. [Telomerase RNA antisense oligonucleotides inhibit growth of human choriocarcinoma xenograft in nude mice].
Chen LL; Zheng W; Chen XJ; Wan L; Shi YF
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):90-2. PubMed ID: 15946546
[TBL] [Abstract][Full Text] [Related]
52. [Inhibition of telomerase with hTERT antisense enhances TNF-alpha-induced apoptosis in prostate cancer cells PC3].
Gao XD; Chen YR
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):723-6. PubMed ID: 17918713
[TBL] [Abstract][Full Text] [Related]
53. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
Fu XH; Zhang JS; Zhang N; Zhang YD
World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
[TBL] [Abstract][Full Text] [Related]
54. [Telomerase activity inhibition and apoptosis induction of BEL-7404 human hepatoma cells by antisense oligonucleotides to telomerase RNA component].
Zhang RG; Wang XW; Xie H
Shi Yan Sheng Wu Xue Bao; 2001 Sep; 34(3):213-8. PubMed ID: 12549223
[TBL] [Abstract][Full Text] [Related]
55. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
56. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
57. Anticancer activity of an essential oil from Cymbopogon flexuosus.
Sharma PR; Mondhe DM; Muthiah S; Pal HC; Shahi AK; Saxena AK; Qazi GN
Chem Biol Interact; 2009 May; 179(2-3):160-8. PubMed ID: 19121295
[TBL] [Abstract][Full Text] [Related]
58. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells.
Kanazawa Y; Ohkawa K; Ueda K; Mita E; Takehara T; Sasaki Y; Kasahara A; Hayashi N
Biochem Biophys Res Commun; 1996 Aug; 225(2):570-6. PubMed ID: 8753802
[TBL] [Abstract][Full Text] [Related]
59. Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
Ozawa T; Gryaznov SM; Hu LJ; Pongracz K; Santos RA; Bollen AW; Lamborn KR; Deen DF
Neuro Oncol; 2004 Jul; 6(3):218-26. PubMed ID: 15279714
[TBL] [Abstract][Full Text] [Related]
60. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
